1
|
Degotte G, Frederich M, Francotte P, Franck T, Colson T, Serteyn D, Mouithys-Mickalad A. Targeting Myeloperoxidase Activity and Neutrophil ROS Production to Modulate Redox Process: Effect of Ellagic Acid and Analogues. Molecules 2023; 28:molecules28114516. [PMID: 37298992 DOI: 10.3390/molecules28114516] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/13/2023] [Revised: 05/29/2023] [Accepted: 05/30/2023] [Indexed: 06/12/2023] Open
Abstract
Malaria is an infectious disease caused by a Plasmodium genus parasite that remains the most widespread parasitosis. The spread of Plasmodium clones that are increasingly resistant to antimalarial molecules is a serious public health problem for underdeveloped countries. Therefore, the search for new therapeutic approaches is necessary. For example, one strategy could consist of studying the redox process involved in the development of the parasite. Regarding potential drug candidates, ellagic acid is widely studied due to its antioxidant and parasite-inhibiting properties. However, its low oral bioavailability remains a concern and has led to pharmacomodulation and the synthesis of new polyphenolic compounds to improve antimalarial activity. This work aimed at investigating the modulatory effect of ellagic acid and its analogues on the redox activity of neutrophils and myeloperoxidase involved in malaria. Overall, the compounds show an inhibitory effect on free radicals as well as on the enzyme horseradish peroxidase- and myeloperoxidase (HRP/MPO)-catalyzed oxidation of substrates (L-012 and Amplex Red). Similar results are obtained with reactive oxygen species (ROS) produced by phorbol 12-mystate acetate (PMA)-activated neutrophils. The efficiency of ellagic acid analogues will be discussed in terms of structure-activity relationships.
Collapse
Affiliation(s)
- Gilles Degotte
- Laboratory of Medicinal Chemistry, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, 4000 Liège, Belgium
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium
| | - Michel Frederich
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium
| | - Pierre Francotte
- Laboratory of Medicinal Chemistry, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, 4000 Liège, Belgium
| | - Thierry Franck
- Centre for Oxygen, Research & Development (CORD), Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium
| | - Thomas Colson
- Laboratory of Medicinal Chemistry, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, 4000 Liège, Belgium
| | - Didier Serteyn
- Centre for Oxygen, Research & Development (CORD), Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium
- Department of Clinical Veterinary, Equine Clinic, Large Animal Surgery, Faculty of Veterinary Medicine, University of Liège, 4000 Liège, Belgium
| | - Ange Mouithys-Mickalad
- Centre for Oxygen, Research & Development (CORD), Center of Interdisciplinary Research on Medicines (CIRM), University of Liège, 4000 Liège, Belgium
| |
Collapse
|
2
|
Degotte G, Pendeville H, Di Chio C, Ettari R, Pirotte B, Frédérich M, Francotte P. Dimeric polyphenols to pave the way for new antimalarial drugs. RSC Med Chem 2023; 14:715-733. [PMID: 37122550 PMCID: PMC10131582 DOI: 10.1039/d2md00392a] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2022] [Accepted: 02/07/2023] [Indexed: 02/12/2023] Open
Abstract
Because of the threat of resistant Plasmodium sp., new orally active antimalarials are urgently needed. Inspired by the structure of ellagic acid, exhibiting potent in vivo and in vitro antiplasmodial effects, polyphenolic structures possessing a similar activity-safety profile were synthesized. Indeed, most exhibited a marked in vitro effect (IC50 < 4 μM) on resistant P. falciparum, without any detrimental effects reported during the toxicity assays (hemolysis, cytotoxicity, in vivo). In addition, they possessed a greater hydrosolubility (from 7 μM to 2.7 mM) compared to ellagic acid. Among them, 30 is the most promising for antimalarial purposes since it displayed a significant parasitaemia reduction after oral administration in mice (50 mg kg-1) compared to the orally ineffective ellagic acid. In conclusion, our investigations led to the identification of a promising scaffold, which could bring new insights for malaria treatment.
Collapse
Affiliation(s)
- Gilles Degotte
- Laboratory of Medicinal Chemistry, CIRM, Department of Pharmacy, University of Liège Quartier Hôpital - B36 Tower 4, +5, Avenue Hippocrate 15 4000 Liège Belgium
- Laboratory of Pharmacognosy, CIRM, Department of Pharmacy, University of Liège Quartier Hôpital - B36 Tower 4, +5, Avenue Hippocrate 15 4000 Liège Belgium
| | - Hélène Pendeville
- Platform Zebrafish facility & transgenics, GIGA, University of Liège Quartier Hôpital - B34, +2, Avenue de l'Hôpital 11 4000 Liège Belgium
| | - Carla Di Chio
- Dipartimento di Scienze chimiche, biologiche, farmaceutiche e ambientali, Università degli Studi di Messina Viale Annunziata 98168 Messina Italy
| | - Roberta Ettari
- Dipartimento di Scienze chimiche, biologiche, farmaceutiche e ambientali, Università degli Studi di Messina Viale Annunziata 98168 Messina Italy
| | - Bernard Pirotte
- Laboratory of Medicinal Chemistry, CIRM, Department of Pharmacy, University of Liège Quartier Hôpital - B36 Tower 4, +5, Avenue Hippocrate 15 4000 Liège Belgium
| | - Michel Frédérich
- Laboratory of Pharmacognosy, CIRM, Department of Pharmacy, University of Liège Quartier Hôpital - B36 Tower 4, +5, Avenue Hippocrate 15 4000 Liège Belgium
| | - Pierre Francotte
- Laboratory of Medicinal Chemistry, CIRM, Department of Pharmacy, University of Liège Quartier Hôpital - B36 Tower 4, +5, Avenue Hippocrate 15 4000 Liège Belgium
| |
Collapse
|
3
|
Bonnet O, Beniddir MA, Champy P, Degotte G, Mamede L, Desdemoustier P, Ledoux A, Tchinda AT, Angenot L, Frédérich M. Unveiling antiplasmodial alkaloids from a cumulative collection of Strychnos extracts by multi-informative molecular networks. Front Mol Biosci 2022; 9:967012. [PMID: 36225255 PMCID: PMC9548993 DOI: 10.3389/fmolb.2022.967012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/12/2022] [Accepted: 08/29/2022] [Indexed: 11/13/2022] Open
Abstract
Malaria, a disease known for thousands of years and caused by parasites of the Plasmodium genus, continues to cause many deaths throughout the world today, particularly due to the emergence of parasite resistance to the current therapeutic arsenal. Plants of the Strychnos genus, remarkable due to their multiple traditional uses as well as their alkaloid content, are promising candidates to develop new antimalarial treatments. Indeed, previous research on this plant group has shown promising (≤ 5 µg/ml) or good (between 5 and 15 µg/ml) antiplasmodial activities. Using the chloroquine-sensitive strain of Plasmodium falciparum (3D7), and artemisinin as positive control, a screening of antiplasmodial activities from 43 crude methanolic extracts from 28 species of the Strychnos genus was carried out in three independent assays. A total of 12 extracts had good (6 extracts) or promising (6 extracts) antiplasmodial activities. These results allowed both to confirm known activities but also to detect new ones. These extracts were then analyzed by HPLC-ESI(+)-Q/TOF, and the processed MS/MS data allowed to generate a molecular network in which the antiplasmodial activities were implemented as metadata. The exploration of the molecular network revealed the presence of alkaloids still unknown, and potentially active against malaria, in particular alkaloids close to usambarensine and its derivatives. This study shows that the emergence of molecular networking offers new leads for identifications of alkaloids from the Strychnos genus. The presence of unknown alkaloids potentially active against malaria confirms all the interest to continue in studying the Strychnos genus. Bioassay- and mass-guided fractionations as well as various dereplication tools would allow to identify and characterize these interesting alkaloids further.
Collapse
Affiliation(s)
- Olivier Bonnet
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
- *Correspondence: Olivier Bonnet,
| | - Mehdi A. Beniddir
- Équipe “Chimie des Substances Naturelles” BioCIS, CNRS, Université Paris-Saclay, Châtenay-Malabry, France
| | - Pierre Champy
- Équipe “Chimie des Substances Naturelles” BioCIS, CNRS, Université Paris-Saclay, Châtenay-Malabry, France
| | - Gilles Degotte
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
| | - Lúcia Mamede
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
| | - Pauline Desdemoustier
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
| | - Allison Ledoux
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
| | - Alembert Tiabou Tchinda
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
- Institute of Medical Research and Medicinal Plants Studies (IMPM), Yaoundé, Cameroon
| | - Luc Angenot
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
| | - Michel Frédérich
- Laboratory of Pharmacognosy, Center of Interdisciplinary Research on Medicines (CIRM), University of Liege, Liege, Belgium
| |
Collapse
|
4
|
Degotte G, Pirotte B, Frédérich M, Francotte P. Polyhydroxybenzoic acid derivatives as potential new antimalarial agents. Arch Pharm (Weinheim) 2021; 354:e2100190. [PMID: 34346088 DOI: 10.1002/ardp.202100190] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/17/2021] [Revised: 06/27/2021] [Accepted: 07/01/2021] [Indexed: 11/11/2022]
Abstract
With more than 200 million cases and 400,000 related deaths, malaria remains one of the deadliest infectious diseases of 2021. Unfortunately, despite the availability of efficient treatments, we have observed an increase in people infected with malaria since 2015 (from 211 million in 2015 to 229 million in 2019). This trend could partially be due to the development of resistance to all the current drugs. Therefore, there is an urgent need for new alternatives. We have, thus, selected common natural scaffolds, polyhydroxybenzoic acids, and synthesized a library of derivatives to better understand the structure-activity relationships explaining their antiplasmodial effect. Only gallic acid derivatives showed a noticeable potential for further developments. Indeed, they showed a selective inhibitory effect on Plasmodium (IC50 ~20 µM, SI > 5) often associated with interesting water solubility. Moreover, this has confirmed the critical importance of free phenolic functions (pyrogallol moiety) for the antimalarial effect. Methyl 4-benzoxy-3,5-dihydroxybenzoate (39) has, for the first time, been recognized as a potential lead for future research because of its marked inhibitory activity against Plasmodium falciparum and its significant hydrosolubility (3.72 mM).
Collapse
Affiliation(s)
- Gilles Degotte
- Department of Pharmacy, Laboratory of Medicinal Chemistry, CIRM, University of Liège, Liège, Belgium.,Department of Pharmacy, Laboratory of Pharmacognosy, CIRM, University of Liège, Liège, Belgium
| | - Bernard Pirotte
- Department of Pharmacy, Laboratory of Medicinal Chemistry, CIRM, University of Liège, Liège, Belgium
| | - Michel Frédérich
- Department of Pharmacy, Laboratory of Pharmacognosy, CIRM, University of Liège, Liège, Belgium
| | - Pierre Francotte
- Department of Pharmacy, Laboratory of Medicinal Chemistry, CIRM, University of Liège, Liège, Belgium
| |
Collapse
|
5
|
Degotte G, Pirotte B, Francotte P, Frédérich M. Overview of natural antiplasmodials from the last decade to inspire medicinal chemistry. Curr Med Chem 2021; 28:6199-6233. [PMID: 33781183 DOI: 10.2174/0929867328666210329112354] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/22/2020] [Revised: 01/11/2021] [Accepted: 01/26/2021] [Indexed: 11/22/2022]
Abstract
BACKGROUND Despite the major advances in the fight against this parasitic disease, malaria remains a major cause of concerns in 2020. This infection, mainly due to Plasmodium falciparum, causes every year more than 200 million of cases and hundreds of thousands of deaths in developing regions, mostly in Africa. The last statistics show an increase of cases for the third consecutive year, from 211 million in 2015, it has reached 229 million in 2019. This trend could be partially explained by the appearance of resistances to all the used antimalarials, even to artemisinin. Thus, the design of new anti-Plasmodium compounds is an urgent need. For thousands of years, nature has offered to humans the medicines to cure their diseases or the inspiration for development of new active principles. It seems then logical to explore the natural sources to find new molecules to treat this parasitosis. METHOD Therefore, this review reports and analyzes the extracts (plants, bacteria, sponges, fungi) and the corresponding isolated compounds showing antiplasmodial properties between 2013 and 2019. RESULTS & CONCLUSION Nature remains a major source of active compounds. Indeed, 648 molecules from various origins, mostly plants, have been reported for their inhibitory effect on Plasmodium falciparum. Among them, 188 scaffolds were defined as highly active with IC50 ≤ 5 µM and have been reported here in details. Moreover, the most active compounds showed a large variety of structures: flavonoids, triterpenes, alkaloids... Therefore, these compounds could be an interesting source of inspiration for medicinal chemists. May-be several of these molecules should become the next leads for malaria treatment.
Collapse
Affiliation(s)
- Gilles Degotte
- Laboratory of Medicinal Chemistry, Faculty of Medicine, University of Liège, Liège. Belgium
| | - Bernard Pirotte
- Laboratory of Medicinal Chemistry, Faculty of Medicine, University of Liège, Liège. Belgium
| | - Pierre Francotte
- Laboratory of Medicinal Chemistry, Faculty of Medicine, University of Liège, Liège. Belgium
| | - Michel Frédérich
- Laboratory of Pharmacognosy, Faculty of Medicine, University of Liège, Liège. Belgium
| |
Collapse
|
6
|
Alson SG, Jansen O, Cieckiewicz E, Rakotoarimanana H, Rafatro H, Degotte G, Francotte P, Frederich M. In-vitro and in-vivo antimalarial activity of caffeic acid and some of its derivatives. J Pharm Pharmacol 2018; 70:1349-1356. [DOI: 10.1111/jphp.12982] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2018] [Accepted: 06/27/2018] [Indexed: 01/06/2023]
Abstract
Abstract
Objectives
To explore the in-vitro and in-vivo antimalarial potential of caffeic acid and derivatives.
Methods
Two common phenolic acids (caffeic acid and chlorogenic acid) were evaluated for in-vitro and in-vivo antiplasmodial activity in comparison with some semi-synthetic derivatives that were synthesized. An in-vitro assay based on plasmodial lactate dehydrogenase activity, and the classical in-vivo 5-day suppressive test from Peters on an artemisinin-resistant Plasmodium berghei strain was used. Parasitic stage sensitivity to ethyl caffeate was determined in this work.
Key findings
Phenolic acid esters derivatives showed better antiplasmodial activity than corresponding phenolic acids. The derivative with the highest in-vitro activity being caffeic acid ethyl ester, exhibiting an IC50 = 21.9 ± 9.4 μm. Ethyl caffeate and methyl caffeate were then evaluated for antimalarial activity in vivo and ethyl caffeate showed a growth inhibition of 55% at 100 mg/kg. Finally, it seems that ethyl caffeate blocks the growth of young parasitic forms.
Conclusions
Our study provides evidence for an antimalarial potential of caffeic acid derivatives which are common in several medicinal plants traditionally used against malaria. It also demonstrates the possibility to use such derivatives in the treatment of malaria.
Collapse
Affiliation(s)
- Sylvain G Alson
- Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les Médicaments (CIRM), Université de Liège, Liège, Belgium
- Laboratoire d’Évaluation Pharmaco Clinique (LEPC), Institut Malgache de Recherches Appliquées (IMRA), Fondation Albert et Suzanne Rakoto-Ratsimamanga, Antananarivo, Madagascar
| | - Olivia Jansen
- Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les Médicaments (CIRM), Université de Liège, Liège, Belgium
| | - Ewa Cieckiewicz
- Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les Médicaments (CIRM), Université de Liège, Liège, Belgium
| | - Hajatiana Rakotoarimanana
- Laboratoire d’Évaluation Pharmaco Clinique (LEPC), Institut Malgache de Recherches Appliquées (IMRA), Fondation Albert et Suzanne Rakoto-Ratsimamanga, Antananarivo, Madagascar
| | - Herintsoa Rafatro
- Laboratoire d’Évaluation Pharmaco Clinique (LEPC), Institut Malgache de Recherches Appliquées (IMRA), Fondation Albert et Suzanne Rakoto-Ratsimamanga, Antananarivo, Madagascar
| | - Gilles Degotte
- Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les Médicaments (CIRM), Université de Liège, Liège, Belgium
- Laboratoire de Chimie Pharmaceutique, Centre Interdisciplinaire de Recherches sur les Médicaments (CIRM), Université de Liège, Liège, Belgium
| | - Pierre Francotte
- Laboratoire de Chimie Pharmaceutique, Centre Interdisciplinaire de Recherches sur les Médicaments (CIRM), Université de Liège, Liège, Belgium
| | - Michel Frederich
- Laboratoire de pharmacognosie, Centre Interdisciplinaire de Recherches sur les Médicaments (CIRM), Université de Liège, Liège, Belgium
| |
Collapse
|